WP
GALT icon

WealthPLAN Partners’s Galectin Therapeutics GALT Stock Holding History

WealthPLAN Partners’s Portfolio GALT Stock Details GALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Hold
0
– – – 269
2017
Q1 		– Hold
0
– – – 459
2016
Q3 		$2.77K Sell
2,500
-2,500
-50% -$4.45K ﹤0.01% 814
2016
Q2 		$3.68K Buy
+5,000
New +$7.33K ﹤0.01% 2087
2015
Q4 		$4.11K Buy
+7,500
New +$17.2K ﹤0.01% 1373
2015
Q2 		$7K Hold
2,500
– – ﹤0.01% 326
2015
Q1 		$8K Buy
+2,500
New +$8.93K ﹤0.01% 393

Other funds holding GALT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCA
Benchmark Capital Advisors New York $100M AUM 0.8% 1-Year Est. Return
CCM
Courage Capital Management Nashville, Tennessee $70.6M AUM 13.29% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $2.24B AUM 17.11% 1-Year Est. Return